-
06-Dec-2026
-
05-Dec-2026
-
06-Dec-2026For years, regulation has been viewed as one of the biggest barriers to bringing advanced therapies to patients'slow approval timelines, rigid frameworks, and fragmented global pathways. But across se ...
-
05-Dec-2026
-
06-Dec-2026
-
06-Dec-2026Saudi Arabia is taking a bold step in advanced therapies with the Kingdom's first national cell and gene therapy hub at King Faisal Specialist Hospital. Once operational, the facility will deliver 2,4 ...
-
05-Dec-2026Moving an allogeneic cell therapy from breakthrough research at the bench to a multi-center, global Phase 3 clinical trial is incredibly complex. If you don't have a proven roadmap for international c ...
-
06-Dec-2026
-
06-Dec-2026
-
Coffee Break05-Dec-2026
-
06-Dec-2026The science behind advanced cell therapies has been proven, but commercial sustainability is currently hitting a massive wall: manufacturing. Traditional production is heavily dependent on manual inte ...
-
06-Dec-2026
-
Unique Populations, Faster Breakthroughs: Unlocking Global Opportunities for Advanced Therapy Trials05-Dec-2026As the race to develop next-generation cell and gene therapies accelerates, one of the biggest bottlenecks remains patient identification and trial recruitment. Increasingly, sponsors are looking beyo ...
-
06-Dec-2026Countries such as Saudi Arabia and the United Arab Emirates are rapidly emerging as credible destinations for global clinical research, supported by national strategies like Saudi Vision 2030 and UAE ...
-
05-Dec-2026
-
Advancing Rare Disease & Orphan Therapy Innovation in the Middle East05-Dec-2026The Middle East is rapidly becoming a hub for rare disease and orphan therapy innovation, driven by high prevalence of inherited disorders, ambitious national genomics programs, and a growing life sci ...
-
06-Dec-2026As the cell and gene therapy industry scales from breakthrough science to global manufacturing and commercial delivery, one challenge continues to loom large: talent. From bioprocess engineers and reg ...
-
06-Dec-2026
-
Dhuhr Prayer & Coffee Break06-Dec-2026
-
Dhuhr Prayer & Coffee Break05-Dec-2026
-
05-Dec-2026Building a fully integrated cell and gene therapy ecosystem is one of the most complex challenges facing emerging biotech markets today. But translating academic research into scalable, sustainable in ...
-
05-Dec-2026Today, most cell and gene therapies are manufactured in a small number of locations in the US and Europe, creating global supply bottlenecks that delay patient access and increase costs. Across the wo ...
-
06-Dec-2026
-
06-Dec-2026
-
06-Dec-2026AI has the potential to transform cell and gene therapy manufacturing ' from optimising bioprocessing and quality control to reducing costs and scaling production. For the Middle East, this presents a ...
-
05-Dec-2026In the Kingdom, investment decisions are increasingly shaped by long-term national priorities aligned with Saudi Vision 2030 and the National Biotechnology Strategy. Investors are not only evaluating ...
-
06-Dec-2026
-
05-Dec-2026In this session, learn how early stage biotechs can design scalable manufacturing platforms from day 1 with the ultimate goal of driving therapy costs under $20000 and discover key lessons and mistake ...
-
Lunch06-Dec-2026
-
Lunch05-Dec-2026
-
06-Dec-2026Advanced therapies don't succeed in isolation. They thrive within interconnected ecosystems that span discovery, translational science, manufacturing, regulation, and patient access. This session expl ...
-
06-Dec-2026
-
05-Dec-2026What would convince equipment providers, GMP modular builders, and platform developers to establish local operations? A discussion on incentives, partnerships, and long-term strategic positioning.
-
06-Dec-2026
-
05-Dec-2026The global advanced therapy market is highly fragmented. While Europe possesses world-class scientific research, complex regulatory bottlenecks have historically choked commercialization'causing the E ...
-
Asr Prayer Break05-Dec-2026
-
05-Dec-2026Discover how investors can create meaningful returns while supporting Saudi Arabia's biotech ambitions. This session dives into early-stage portfolio strategies, risk management, and how to select ven ...
-
05-Dec-2026' Step by step pathway for regulatory, clinical, manufacturing, commercial entry ' What documentation, partnerships, and timelines global biotechs should expect ' Practical do's/don'ts based on typica ...
-
05-Dec-2026China has become one of the fastest-growing cell and gene therapy markets in the world, with a rapidly expanding pipeline, significant investment, and a growing number of clinical trials. However, reg ...
-
05-Dec-2026For decades, the US has been the undisputed engine of biotech innovation'dominating venture capital flows, clinical development, and the commercialization of breakthrough therapies. But as costs rise ...
-
05-Dec-2026What types of global tenants KSA should attract (CDMOs, modality specialists, platforms) What tenants require: incentives, infrastructure, labor, demand guarantee Lessons from Singapore, Ireland, Kore ...
-
05-Dec-2026
-
Theatre 1 (Zafir)05-Dec-2026
- Plenary
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Ut odio. Nam sed est. Nam a risus et est iaculis adipiscing. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia Curae; Integer ut justo. In tincidunt viverra nisl.
-
InterContinental Hotel, Rooftop space05-Dec-2026
- Investment Summit
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Ut odio. Nam sed est. Nam a risus et est iaculis adipiscing. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia ...